Efficacy, safety of combined perindopril and indapamide low-dose therapy in patients with arterial hypertension and metabolic syndrome
Aim. To study clinical, hemodynamic, and metabolic effects of 12-week therapy with Noliprel® (perindopril 2 mg plus indapamide 0.625 mg) in patients with arterial hypertension (AH) and metabolic syndrome (MS). Material and methods. Twenty-five patients with AH and MS were enrolled in the study. At b...
Saved in:
| Main Authors: | O. N. Andreeva, I. M. Korochkin, N. P. Rechnova, V. Yu. Pibovarov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2005-06-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/968 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effectiveness and safety of the full-dose combination therapy with perindopril A and indapamide (10 mg/2,5 mg) in patients with arterial hypertension
by: M. G. Glezer, et al.
Published: (2012-10-01) -
Triple fixed-dose combination of amlodipine, indapamide and perindopril for hypertension in patients with stable coronary artery disease and abdominal obesity
by: E. A. Polyakova, et al.
Published: (2024-02-01) -
Clinical efficacy of a fixed-dose combination of amlodipine/indapamide/perindopril in patients with hypertension and multiple risk factors
by: A. A. Pirozhenko, et al.
Published: (2023-11-01) -
Fixed-dose perindopril and indapamide combination: in hospital effectiveness in arterial hypertension patients with obstructive sleep apnoea syndrome
by: A. Yu. Litvin, et al.
Published: (1970-01-01) -
Effectiveness and safety of a fixed, low-dose perindopril/ indapamide combination in patients with arterial hypertension: real-world clinical practice data (STRATEGYA, a multi-center, open, prospective study)
by: T. V. Matrynyuk, et al.
Published: (1970-01-01)